Epinephrine Auto-Injector Market By Application (Anaphylaxis, Diabetes, Rheumatoid Arthritis), Technology (Manual Auto-injector, Automated Auto-injector), Design (Standardized Auto-injector, Customized Auto-injector), Distribution Channel (Pharmacy, Hospitals), Usability (Reusable Auto-injector, Disposable Auto-injector), Product Type (Prefilled Auto-injector, Fillable Auto-injector)

The Global Epinephrine Auto-injector market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Market Overview:

Epinephrine auto-injector is a pen shaped device that is used for the treatment of anaphylaxis in which epinephrine (adrenaline) is present as a colorless solution. Anaphylaxis is a severe allergic reaction which has a tendency to get developed in the patients suffering from asthma, cardiac arrest and various other allergies. Adrenaline, if reached to the blood stream within time, can help in the considerable reduction of the risk of life threatening allergy. The major facility provided by this equipment is that it can also be used by an untrained person for the treatment as it is has a simple handling. One of the major drivers for the growth of epinephrine auto-injector market is the rising occurrence of allergies amongst people of different ages. Due to emerging new drug delivery systems and formulations combined with rapid development and innovation in the biological drugs is another factor driving the growth of the market. According to World Allergy Organization, IM injections are best for the treatment of anaphylaxis and also according to Food Allergy Research and Education, anaphylaxis affects one among every 13 children under eighteen years of age. On the other hand, deadly side effects such as cerebral hemorrhage, cardiac arrhythmia and pulmonary edema due to excess epinephrine usage is expected to hamper the growth of the global market. In addition, high costs, product recalls and regulatory issues are some other concerns that can pose challenge to the market. The global epinephrine auto-injector market is moderately fragmented in nature due to the presence of few global market players. Factors such as increasing demand for targeted drug delivery systems for the treatment of severe diseases, increasing trend of self-medication practices and increasing awareness regarding anaphylactic shocks are expected to provide growth opportunities for the global epinephrine auto-injector market in the years to come. The report provides detailed qualitative and quantitative analysis of the Epinephrine Auto-injector Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely application, technology and design in each of the major regions.

Epinephrine Auto-injector Market Segmentation

By Application •Anaphylaxis •Diabetes •Rheumatoid Arthritis By Technology  •Manual Auto-injector •Automated Auto-injector By Design  •Standardized Auto-injector •Customized Auto-injector. By Distribution Channel •Pharmacy •Hospitals By Usability  •Reusable Auto-injector •Disposable Auto-injector By Product Type •Prefilled Auto-injector •Fillable Auto-injector By Geography •North America oU.S. oCanada oMexico •Europe oU.K. oFrance oGermany oItaly oSpain oRest of Europe •Asia-Pacific oChina oJapan oIndia oKorea oRest of APAC •South America oBrazil oRest of South America •Rest of the World oMiddle East oAfrica

CHAPTER 1. INTRODUCTION
1.1. RESEARCH METHODOLOGY
1.1.1. ERC desk research
1.1.2. ERC data synthesis
1.1.3. Data validation and market feedback
1.1.4. ERC data sources
CHAPTER 2. EPINEPHRINE AUTO-INJECTOR MARKET OVERVIEW
2.1. EPINEPHRINE AUTO-INJECTOR MARKET INTRODUCTION
2.2. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET PRODUCTION AND GROWTH RATE, 2017-2025
2.2.1. Global Epinephrine Auto-injector Production (VOLUME) and Growth Rate (%), (2017-2025)
2.3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET CAPACITY AND GROWTH RATE, 2017-2025
2.3.1. Global Epinephrine Auto-injector Capacity (VOLUME) and Growth Rate (%), (2017-2025)
2.4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET REVENUE AND GROWTH RATE, 2017-2025
2.4.1. Global Epinephrine Auto-injector Market Revenue (Million USD) and Growth Rate (%), (2017-2025)
2.5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET CONSUMPTION AND GROWTH RATE, 2017-2025
2.5.1. Global Epinephrine Auto-injector Consumption (VOLUME) and Growth Rate (%), (2017-2025)
CHAPTER 3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET BY PRODUCT TYPE, 2017-2025
3.1. PREFILLED AUTO-INJECTOR
3.2. FILLABLE AUTO-INJECTOR
3.3. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET REVENUE BY PRODUCT TYPE, 2017-2025
3.3.1. Global Epinephrine Auto-injector Market Revenue (Million USD) and Share (%) By Product Type, 2017-2025
3.3.2. Prefilled Auto-injector Market Revenue and Growth Rate, 2017-2025
3.3.3. Fillable Auto-injector Market Revenue and Growth Rate, 2017-2025
3.4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET PRODUCTION BY PRODUCT TYPE, 2017-2025
3.4.1. Global Epinephrine Auto-injector Market Production (Volume) and Share (%) By Product Type, 2017-2025
3.4.2. Prefilled Auto-injector Market Production and Growth Rate, 2017-2025
3.4.3. Fillable Auto-injector Market Production and Growth Rate, 2017-2025
Note: Similar information coverage has been provided for technology, design, distribution channel and usability segment.
CHAPTER 4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET BY APPLICATION, 2017-2025
4.1. ANAPHYLAXIS
4.2. DIABETES
4.3. RHEUMATOID ARTHRITIS
4.4. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET REVENUE BY APPLICATION, 2017-2025
4.4.1. Global Epinephrine Auto-injector Market Revenue (Million USD) and Share (%) By Application, 2017-2025
4.4.2. Anaphylaxis Market Revenue and Growth Rate, 2017-2025
4.4.3. Diabetes Market Revenue and Growth Rate, 2017-2025
4.4.4. Rheumatoid Arthritis Market Revenue and Growth Rate, 2017-2025
4.5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET CONSUMPTION BY APPLICATION, 2017-2025
4.5.1. Global Epinephrine Auto-injector Market Consumption (Volume) and share (%) By Application, 2017-2025
4.5.2. Anaphylaxis Market Consumption and Growth Rate, 2017-2025
4.5.3. Diabetes Market Consumption and Growth Rate, 2017-2025
4.5.4. Rheumatoid Arthritis Market Consumption and Growth Rate, 2017-2025
CHAPTER 5. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET BY REGION, 2017-2025
5.1. NORTH AMERICA
5.1.1. U.S.
5.1.2. Canada
5.1.3. Mexico
5.2. EUROPE
5.2.1. U.K.
5.2.2. France
5.2.3. Germany
5.2.4. Italy
5.2.5. Spain
5.2.6. Rest of Europe
5.3. ASIA PACIFIC
5.3.1. China
5.3.2. Japan
5.3.3. India
5.3.4. Korea
5.3.5. Rest of APAC
5.4. SOUTH AMERICA
5.4.1. Brazil
5.4.2. Rest of South America
5.5. REST OF THE WORLD
5.5.1. Middle East
5.5.2. Africa
5.6. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET REVENUE BY REGION, 2017-2025
5.6.1. Global Epinephrine Auto-injector Market Revenue (Million USD) and Share (%) By Region, 2017-2025
5.6.2. North America Market Revenue and Growth Rate, 2017-2025
5.6.3. Europe Market Revenue and Growth Rate, 2017-2025
5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025
5.6.5. South America Market Revenue and Growth Rate, 2017-2025
5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025
CHAPTER 6. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025
6.1. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025
6.1.1. Global Epinephrine Auto-injector Market Production (Volume) and Share (%) By Region, 2017-2025
6.1.2. Global Epinephrine Auto-injector Market Consumption (Volume) and Share (%) By Region, 2017-2025
6.1.3. North America Market Production and Consumption, 2017-2025
6.1.4. Europe Market Production and Consumption, 2017-2025
6.1.5. Asia Pacific Market Production and Consumption, 2017-2025
6.1.6. South America Market Production and Consumption, 2017-2025
6.1.7. Rest of the World Market Production and Consumption, 2017-2025
CHAPTER 7. MARKET DETERMINANTS
7.1. MARKET DRIVERS
7.2. MARKET RESTRAINTS
7.3. MARKET OPPORTUNITIES
7.4. MARKET DETERMINANTS RADAR CHART
CHAPTER 8. GLOBAL EPINEPHRINE AUTO-INJECTOR MARKET COMPETITION BY MANUFACTURERS
8.1. GLOBAL EPINEPHRINE AUTO-INJECTOR PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025)
8.1.1. Global Epinephrine Auto-injector Production (VOLUME) and Share (%) by Manufacturers (2017-2025)
8.2. GLOBAL EPINEPHRINE AUTO-INJECTOR REVENUE AND SHARE BY MANUFACTURERS (2017-2025)
8.2.1. Global Epinephrine Auto-injector Revenue (Million USD) and Share (%) by Manufacturers (2017-2025)
8.3. EPINEPHRINE AUTO-INJECTOR MARKET COMPETITIVE SITUATION AND TRENDS
8.3.1. Epinephrine Auto-injector Market Share (%) of Top 3 Manufacturers
8.3.2. Epinephrine Auto-injector Market Share (%) of Top 5 Manufacturers
CHAPTER 9. GLOBAL EPINEPHRINE AUTO-INJECTOR MANUFACTURERS ANALYSIS
9.1. ANTARES PHARMA INC.
9.1.1. Business Overview
9.1.2. Company Basic Information
9.1.3. Epinephrine Auto-injector Product Details
9.1.4. Antares Pharma Inc. Epinephrine Auto-injector Production, Revenue and Gross Margin
9.2. PFIZER INC.
9.2.1. Business Overview
9.2.2. Company Basic Information
9.2.3. Epinephrine Auto-injector Product Details
9.2.4. Pfizer Inc. Epinephrine Auto-injector Production, Revenue and Gross Margin
9.3. BIOGEN IDEC INC.
9.3.1. Business Overview
9.3.2. Company Basic Information
9.3.3. Epinephrine Auto-injector Product Details
9.3.4. Biogen Idec Inc. Epinephrine Auto-injector Production, Revenue and Gross Margin
9.4. DICKINSON AND COMPANY
9.4.1. Business Overview
9.4.2. Company Basic Information
9.4.3. Epinephrine Auto-injector Product Details
9.4.4. Dickinson and Company Epinephrine Auto-injector Production, Revenue and Gross Margin
9.5. UNILIFE CORPORATION
9.5.1. Business Overview
9.5.2. Company Basic Information
9.5.3. Epinephrine Auto-injector Product Details
9.5.4. Unilife Corporation Epinephrine Auto-injector Production, Revenue and Gross Margin
9.6. BECTON
9.6.1. Business Overview
9.6.2. Company Basic Information
9.6.3. Epinephrine Auto-injector Product Details
9.6.4. Becton Epinephrine Auto-injector Production, Revenue and Gross Margin
9.7. NOVARTIS INTERNATIONAL AG
9.7.1. Business Overview
9.7.2. Company Basic Information
9.7.3. Epinephrine Auto-injector Product Details
9.7.4. Novartis International AG Epinephrine Auto-injector Production, Revenue and Gross Margin
9.8. YPSOMED HOLDINGS AG
9.8.1. Business Overview
9.8.2. Company Basic Information
9.8.3. Epinephrine Auto-injector Product Details
9.8.4. Ypsomed Holdings AG Epinephrine Auto-injector Production, Revenue and Gross Margin
9.9. MYLAN N.V.
9.9.1. Business Overview
9.9.2. Company Basic Information
9.9.3. Epinephrine Auto-injector Product Details
9.9.4. Mylan N.V. Epinephrine Auto-injector Production, Revenue and Gross Margin
9.10. SCANDINAVIAN HEALTH LTD.
9.10.1. Business Overview
9.10.2. Company Basic Information
9.10.3. Epinephrine Auto-injector Product Details
9.10.4. Scandinavian Health Ltd. Epinephrine Auto-injector Production, Revenue and Gross Margin
CHAPTER 10. EPINEPHRINE AUTO-INJECTOR MARKET VALUE CHAIN ANALYSIS
10.1. EPINEPHRINE AUTO-INJECTOR INDUSTRIAL CHAIN ANALYSIS
10.2. EPINEPHRINE AUTO-INJECTOR KEY RAW MATERIALS ANALYSIS
10.2.1. Key Raw Materials
10.2.2. Price Trend of Key Raw Materials
10.2.3. Key Suppliers of Raw Materials
10.3. CONSUMER ANALYSIS
10.3.1. Consumer 1
10.3.2. Consumer 2
10.3.3. Consumer 3
10.3.4. Consumer 4

•Antares Pharma Inc.
•Pfizer Inc.
•Biogen Idec Inc.
•Dickinson and Company
•Unilife Corporation
•Becton
•Novartis International AG
•Ypsomed Holdings AG
•Mylan N.V.
•Scandinavian Health Ltd.

Select License Type

  • $4700
  • $5600
  • $2000
  • Buy Now

Report Highlights:

Complete overview of market
Major drivers, restrain, opportunities, and challenges of the market
Market Trends and how they are boosting the market growth
Changing dynamics in the Market
Complete overview of the market
Historical, Base year, projected, and current market size in terms of value and volume
COVID-19 Impact analysis of the market
Current industry trends and developments

CLIENTS